{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:14:52Z","timestamp":1780647292158,"version":"3.54.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00259-022-05683-2","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T04:35:40Z","timestamp":1643171740000},"page":"2290-2299","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical and pathological predictors for FDG-PET\/CT avidity in patients with marginal zone lymphoma\u2014a retrospective cohort study"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7966-1252","authenticated-orcid":false,"given":"Kim Ben Tikva","family":"Kagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Guz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Buchrits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Gurion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliana","family":"Vaxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Priss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Groshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onofrio A.","family":"Catalano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Sherban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Gafter-Gvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Bernstine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"issue":"1","key":"5683_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","volume":"31","author":"E Zucca","year":"2020","unstructured":"Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(1):17\u201329.","journal-title":"Ann Oncol"},{"issue":"12","key":"5683_CR2","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1182\/blood-2017-03-771915","volume":"130","author":"C Thieblemont","year":"2017","unstructured":"Thieblemont C, Cascione L, Conconi A, Kiesewetter B, Raderer M, Gaidano G, et al. A MALT lymphoma prognostic index. Blood. 2017;130(12):1409\u201317.","journal-title":"Blood"},{"issue":"12","key":"5683_CR3","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","volume":"107","author":"L Arcaini","year":"2006","unstructured":"Arcaini L. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood. 2006;107(12):4643\u20139.","journal-title":"Blood"},{"issue":"2","key":"5683_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/bjh.12011","volume":"159","author":"C Montalb\u00e1n","year":"2012","unstructured":"Montalb\u00e1n C, Abraira V, Arcaini L, Domingo-Domenech E, Guisado-Vasco P, Iannito E, et al. Risk stratification for splenic marginal zone lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. Br J Haematol. 2012;159(2):164\u201371.","journal-title":"Br J Haematol"},{"issue":"2","key":"5683_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2141.2006.06437.x","volume":"136","author":"L Arcaini","year":"2007","unstructured":"Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F, et al. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol. 2007;136(2):301\u20134.","journal-title":"Br J Haematol"},{"issue":"12","key":"5683_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1182\/blood-2015-11-679407","volume":"127","author":"SF Barrington","year":"2016","unstructured":"Barrington SF, Kirkwood AA, Franceschetto A, Fulham MJ, Roberts TH, Almquist H, et al. PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study. Blood. 2016;127(12):1531\u20138.","journal-title":"Blood"},{"issue":"14","key":"5683_CR7","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1200\/JCO.2010.32.5225","volume":"29","author":"BD Cheson","year":"2011","unstructured":"Cheson BD. Role of functional imaging in the management of lymphoma. J Clin Oncol. 2011;29(14):1844\u201354.","journal-title":"J Clin Oncol"},{"issue":"9","key":"5683_CR8","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1093\/annonc\/mdf256","volume":"13","author":"K Spaepen","year":"2002","unstructured":"Spaepen K, Stroobants S, Dupont P, Vandenberghe P, Thomas J, de Groot T, et al. Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin\u2019s lymphoma. Ann Oncol. 2002;13(9):1356\u201363.","journal-title":"Ann Oncol"},{"issue":"2","key":"5683_CR9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1200\/JCO.2011.38.2648","volume":"30","author":"V Safar","year":"2012","unstructured":"Safar V, Dupuis J, Itti E, Jardin F, Fruchart C, Bardet S, et al. Interim [18 F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab. J Clin Oncol. 2012;30(2):184\u201390.","journal-title":"J Clin Oncol"},{"issue":"11","key":"5683_CR10","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1200\/JCO.2008.16.0861","volume":"27","author":"T Terasawa","year":"2009","unstructured":"Terasawa T, Lau J, Bardet S, Couturier O, Hotta T, Hutchings M, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin\u2019s lymphoma and diffuse large B-cell lymphoma: a systematic review. J Clin Oncol. 2009;27(11):1906\u201314.","journal-title":"J Clin Oncol"},{"issue":"3","key":"5683_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-0609.2007.00895.x","volume":"79","author":"C Perry","year":"2007","unstructured":"Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, et al. Diagnostic accuracy of PET\/CT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol. 2007;79(3):205\u20139.","journal-title":"Eur J Haematol"},{"issue":"1","key":"5683_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/cncr.21967","volume":"107","author":"M Karam","year":"2006","unstructured":"Karam M, Novak L, Cyriac J, Ali A, Nazeer T, Nugent F. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas. Cancer. 2006;107(1):175\u201383.","journal-title":"Cancer"},{"issue":"2","key":"5683_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/hon.2578","volume":"37","author":"I Vaxman","year":"2019","unstructured":"Vaxman I, Bernstine H, Kleinstern G, Hendin N, Shimony S, Domachevsky L, et al. FDG PET\/CT as a diagnostic and prognostic tool for the evaluation of marginal zone lymphoma. Hematol Oncol. 2019;37(2):168\u201375.","journal-title":"Hematol Oncol"},{"issue":"10","key":"5683_CR14","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1080\/10428194.2017.1298754","volume":"58","author":"D Albano","year":"2017","unstructured":"Albano D, Bosio G, Giubbini R, Bertagna F. 18F-FDG PET\/CT and extragastric MALT lymphoma: role of Ki-67 score and plasmacytic differentiation. Leuk Lymphoma. 2017;58(10):2328\u201334.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"5683_CR15","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00259-016-3518-y","volume":"44","author":"D Albano","year":"2017","unstructured":"Albano D, Bertoli M, Ferro P, Fallanca F, Gianolli L, Picchio M, et al. 18F-FDG PET\/CT in gastric MALT lymphoma: a bicentric experience. Eur J Nucl Med Mol Imaging. 2017;44(4):589\u201397.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"15","key":"5683_CR16","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1002\/cncr.30672","volume":"123","author":"U Metser","year":"2017","unstructured":"Metser U, Dudebout J, Baetz T, Hodgson DC, Langer DL, MacCrostie P, et al. [18 F]-FDG PET\/CT in the staging and management of indolent lymphoma: a prospective multicenter PET registry study: PET\/CT in Indolent Lymphoma. Cancer. 2017;123(15):2860\u20136.","journal-title":"Cancer"},{"issue":"20","key":"5683_CR17","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1182\/blood-2016-03-657379","volume":"127","author":"M Cazzola","year":"2016","unstructured":"Cazzola M. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues. Blood. 2016;127(20):2361\u20134.","journal-title":"Blood"},{"key":"5683_CR18","doi-asserted-by":"publisher","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA; Alliance, Australasian Leukaemia and Lymphoma Group; Eastern Cooperative Oncology Group; European Mantle Cell Lymphoma Consortium; Italian Lymphoma Foundation; European Organisation for Research; Treatment of Cancer\/Dutch Hemato-Oncology Group; Grupo Espa\u00f1ol de M\u00e9dula \u00d3sea; German High-Grade Lymphoma Study Group; German Hodgkin's Study Group; Japanese Lymphorra Study Group; Lymphoma Study Association; NCIC Clinical Trials Group; Nordic Lymphoma Study Group; Southwest Oncology Group;United Kingdom National Cancer Research Institute. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014 Sep 20;32(27):3059-68. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800.","DOI":"10.1200\/JCO.2013.54.8800"},{"issue":"12","key":"5683_CR19","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.3109\/10428194.2015.1030640","volume":"56","author":"SH Park","year":"2015","unstructured":"Park SH, Lee JJ, Kim HO, Lee DY, Suh C, Jung H-Y, et al. 18 F-Fluorodeoxyglucose (FDG)-positron emission tomography\/computed tomography in mucosa-associated lymphoid tissue lymphoma: variation in 18 F-FDG avidity according to site involvement. Leuk Lymphoma. 2015;56(12):3288\u201394.","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"5683_CR20","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1182\/bloodadvances.2017013698","volume":"2","author":"S Qi","year":"2018","unstructured":"Qi S, Huang MY, Yang Y, Sch\u00f6der H, Teckie S, Noy A, et al. Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma. Blood Adv. 2018;2(6):649\u201355.","journal-title":"Blood Adv"},{"issue":"12","key":"5683_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/annonc\/mdl295","volume":"17","author":"M Hoffmann","year":"2006","unstructured":"Hoffmann M, W\u00f6hrer S, Becherer A, Chott A, Streubel B, Kletter K, et al. 18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference. Ann Oncol. 2006;17(12):1761\u20135.","journal-title":"Ann Oncol"},{"issue":"1","key":"5683_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/hon.2563","volume":"37","author":"D Albano","year":"2019","unstructured":"Albano D, Bosio G, Camoni L, Farina M, Re A, Tucci A, et al. Prognostic role of baseline 18 F - FDG PET \/ CT parameters in MALT lymphoma. Hematol Oncol. 2019;37(1):39\u201346.","journal-title":"Hematol Oncol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-05683-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-022-05683-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-05683-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T05:05:09Z","timestamp":1653282309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-022-05683-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["5683"],"URL":"https:\/\/doi.org\/10.1007\/s00259-022-05683-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}